Back to search results

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Neovascular Age-related Macular Degeneration

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Retina Vitreous Associates of Florida - Saint Petersburg, St. Petersburg, Florida, United States

  • Ophthalmic Consultants of Boston, Boston, Massachusetts, United States

  • Retina Consultants of Texas, Katy, Texas, United States

    Contact: Study coordinator (Marie Chin)
    Contact: Principal Investigator (Charles C Wykoff, MD)

  • Wagner Kapoor Research Institute, Norfolk, Virginia, United States

    Contact: Study coordinator (Chris Riebling)
    Contact: Principal Investigator (Alan Wagner, MD)

  • The Second Hospital Of Anhui Medical University, Hefei, Anhui, China

  • Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

  • Eye Hospital, WMU (Zhejiang Eye Hospital), Wenzhou, Zhejiang, China

  • Beijing Hospital, Beijing, China

  • Peking Union Medical College Hospital, Beijing, China

View source on ClinicalTrials.gov(opens in a new tab)